+17
Shred Apps
For diverse health-conscious segments, including women seeking home-based routines, tactical fitness enthusiasts, and individuals managing GLP-1 medication regimens.
Known for
For diverse health-conscious segments, including women seeking home-based routines, tactical fitness enthusiasts, and individuals managing GLP-1 medication regimens.
Providing specialized fitness and medical tracking tools tailored to specific user demographics and health journeys.
Target audience
Portfolio
Free 18Last updated
GLP-1 Tracker: Pep
v2.0.6
2mo ago
Primary focus
Specialized fitness and medical tracking apps
Scale
studio
Target audience
Diverse health-conscious segments, including women seeking home-based routines, tactical fitness enthusiasts, and individuals managing GLP-1 medication regimens.
The publisher maintains an intense development cadence with 30 releases across the portfolio in the last 6 months and a major release occurring within the last 14 days.
20 apps analysed
GLP-1 shot tracker reminders: Ozempic, Mounjaro, Wegovy, Zepbound, Compound GLP1
Injection site rotation tracking creates specialized health-safety switching costs
Single-market publisher — every app ships only to United States.
Based on 1 of 20 apps with localized market data — more coverage rolling in as scans complete · last scanned .
0
Positive apps
1
Neutral / mixed
0
Negative apps
55/100
Avg sentiment score
Directly competes on the core job-to-be-done of medication adherence and complex reminder scheduling for chronic conditions.
Strategic outlook coming soon.
What fed this analysis
Targets the exact same metabolic health audience with a focus on logging blood glucose and weight trends.
Dominates the diabetes logging space with a gamified UX that directly challenges the 'Pep' engagement model.
Hardware-tethered ecosystem that creates a high barrier to entry for independent tracking apps.
Adjacent utility that captures the same user base seeking to manage the high costs of GLP-1 medications.
Represents the vertical integration of telehealth and prescription fulfillment which is the ultimate destination for GLP-1 users.
Rapidly expanding patient portal with 5 releases in 6 months, signaling a push into mobile-first patient engagement.
High-velocity updates (12 releases in 6 months) indicate a focus on professional-grade patient-provider communication.
